Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

Trial Profile

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Rose bengal sodium (Primary)
  • Indications Malignant melanoma
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 18 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 28 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Jan 2018.
    • 25 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top